LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 CGP60474
10.0
uM
LJP6
 2
G01
 72
hr
 1097 424 3769 0.1125 -0.2519
BT-20 CGP60474
10.0
uM
LJP6
 3
G01
 72
hr
 1097 415 3769 0.1101 -0.2553
BT-20 CHIR-99021
10.0
uM
LJP6
 1
P13
 72
hr
 1097 2583 3769 0.6852 0.5560
BT-20 CHIR-99021
10.0
uM
LJP6
 2
P13
 72
hr
 1097 2840 3769 0.7534 0.6522
BT-20 CHIR-99021
10.0
uM
LJP6
 3
P13
 72
hr
 1097 3011 3769 0.7988 0.7162
BT-20 CP724714
10.0
uM
LJP5
 1
A07
 72
hr
 1097 1780 3769 0.4722 0.2555
BT-20 CP724714
10.0
uM
LJP5
 2
A07
 72
hr
 1097 2409 3769 0.6391 0.4909
BT-20 CP724714
10.0
uM
LJP5
 3
A07
 72
hr
 1097 2512 3769 0.6664 0.5294
BT-20 CP466722
10.0
uM
LJP5
 1
I07
 72
hr
 1097 1807 3769 0.4794 0.2656
BT-20 CP466722
10.0
uM
LJP5
 2
I07
 72
hr
 1097 2113 3769 0.5606 0.3801
BT-20 CP466722
10.0
uM
LJP5
 3
I07
 72
hr
 1097 2119 3769 0.5621 0.3824
BT-20 Crizotinib
10.0
uM
LJP5
 1
A19
 72
hr
 1097 1066 3769 0.2828 -0.0117
BT-20 Crizotinib
10.0
uM
LJP5
 2
A19
 72
hr
 1097 1044 3769 0.2770 -0.0199
BT-20 Crizotinib
10.0
uM
LJP5
 3
A19
 72
hr
 1097 1146 3769 0.3040 0.0182
BT-20 Momelotinib
10.0
uM
LJP5
 1
P07
 72
hr
 1097 994 3769 0.2637 -0.0386
BT-20 Momelotinib
10.0
uM
LJP5
 2
P07
 72
hr
 1097 1055 3769 0.2799 -0.0158
BT-20 Momelotinib
10.0
uM
LJP5
 3
P07
 72
hr
 1097 1138 3769 0.3019 0.0152
BT-20 Dasatinib
10.0
uM
LJP5
 1
D01
 72
hr
 1097 874 3769 0.2319 -0.0835
BT-20 Dasatinib
10.0
uM
LJP5
 2
D01
 72
hr
 1097 1262 3769 0.3348 0.0616
BT-20 Dasatinib
10.0
uM
LJP5
 3
D01
 72
hr
 1097 1159 3769 0.3075 0.0231
BT-20 Dasatinib
10.0
uM
LJP6
 1
I01
 72
hr
 1097 840 3769 0.2228 -0.0963
BT-20 Dasatinib
10.0
uM
LJP6
 2
I01
 72
hr
 1097 787 3769 0.2088 -0.1161
BT-20 Dasatinib
10.0
uM
LJP6
 3
I01
 72
hr
 1097 744 3769 0.1974 -0.1322
BT-20 Dovitinib
10.0
uM
LJP5
 1
E19
 72
hr
 1097 1396 3769 0.3703 0.1118
BT-20 Dovitinib
10.0
uM
LJP5
 2
E19
 72
hr
 1097 1324 3769 0.3512 0.0849